Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Impact of Donor-Recipient Histocompatibility and CMV-Mismatch on Outcome of Allogeneic Stem Cell Transplantation for AML and MDS: A Retrospective Registry Study of the German Stem Cell Transplant Registry (DRST) of the German Working Group for Blood and Marrow Transplantation (DAG-KBT)

Francis A. Ayuk, MD, Dietrich W. Beelen, Prof. Dr. MD, Martin Bornhäuser, MD, Matthias Stelljes, Tajana Zabelina, MD, Jürgen Finke, Guido Kobbe, MD, Daniel Wolff, MD, Eva Maria Wagner, MD, Maximilian Christopeit, MD, Christoph Schmid, MD, Hellmut Ottinger, MD, Christoph Groth, MD, Christoph Faul, MD, Hartmut Bertz, MD, Elena Rachlis, MD, Christine Wolschke, MD, Nicolaus Kröger, MD, Wolfgang Bethge, MD

Blood (2016) 128 (22): 2304.

https://doi.org/10.1182/blood.V128.22.2304.2304

Published: 2016

Journal Articles

Randomized Trial on GvHD Prophylaxis with or without Anti-Human T-Lymphocyte Immunoglobulin ATG-Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation from Matched Unrelated Donors: Final Long-Term Results after 8.6 Years Median Follow-up

Jürgen Finke, MD, Claudia Schmoor, PhD, Wolfgang A Bethge, MD, Hellmut Ottinger, Priv.-Doz. Dr. MD, Matthias Stelljes, Liisa Volin, MD PhD, Dominik Heim, MD, Hartmut Bertz, MD, Olga Grishina, MD, Gerard Socie

Blood (2015) 126 (23): 853.

https://doi.org/10.1182/blood.V126.23.853.853

Published: 2015

Journal Articles

The Functional Distance Between Mismatched HLA-DPB1 Increases Risks of Relapse and Mortality after Unrelated Donor Hematopoietic Cell Transplantation for AML, ALL and MDS: A Refinement of the T Cell Epitope Group Algorithm for Permissive Mismatches

Dietrich W. Beelen, Prof. Dr. MD, Pietro Crivello, PhD, Andreas Heinold, Dr. sc. hum., Sabine Riebschläger, Falko M. Heinemann, Dr. rer. nat., Vera Rebmann, Priv.-Doz. Dr. rer. MDc., Monika Lindemann, Prof. Dr. MD, Hellmut Ottinger, Priv.-Doz. Dr. MD, Peter Horn, Prof. Dr. MD, Katharina Fleischhauer, MD

Blood (2015) 126 (23): 4288.

https://doi.org/10.1182/blood.V126.23.4288.4288

Published: 2015

Journal Articles

Reduced Relapse Risk In Patients With AML After Hhcmv-Replication Post Transplantation-First Results Of a Prospective Registration Trial

Ahmet H. Elmaagacli, MD, Nina-Kristin Steckel, MD, Meltem Kekec, Rudolf Trenschel, Markus Ditschkowski, MD, Tanja Gromke, Sandra Christoph, Hellmut Ottinger, MD, Dietrich Beelen, Michael Koldehoff, MD

Blood (2013) 122 (21): 5503.

https://doi.org/10.1182/blood.V122.21.5503.5503

Published: 2013

Journal Articles

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Nina Kristin Steckel, M.D., Markus Ditschkowski, MD, Christoph Groth, M.D., Gerda Silling, MD, U. Krug, MD, Rudolf Trenschel, MD, Hellmut Ottinger, MD, Wolfgang E Berdel, MD, Michael Koldehoff, MD, Ahmet H. Elmaagacli, Dietrich Beelen, MD, Matthias Stelljes, MD

Blood (2013) 122 (21): 4525.

https://doi.org/10.1182/blood.V122.21.4525.4525

Published: 2013

Journal Articles

Human Chorionic Gonadotropin Hormone Induces Indoleamine 2,3-Dioxygenase and Interleukin-10 Expression In Patients With Graft-Versus-Host-Disease

Ahmet H. Elmaagacli, MD, Markus Ditschkowski, MD, Nina-Kristin Steckel, MD, Hellmut Ottinger, MD, Uwe Hillen, MD, Rudolf Trenschel, Dietrich Beelen, MD, Michael Koldehoff, MD

Blood (2013) 122 (21): 911.

https://doi.org/10.1182/blood.V122.21.911.911

Published: 2013

Journal Articles

CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in Lymphoma

Ahmet H Elmaagacli, MD, PhD, Michael Koldehoff, MD, Nina K. Steckel, MD, Yael Hegerfeldt, MD, Markus Ditschkowski, Sandra Christoph, MD, Tanja Gromke, Rudof Stefan Ross, Hellmut Ottinger, Dietrich Beelen

Blood (2012) 120 (21): 1635.

https://doi.org/10.1182/blood.V120.21.1635.1635

Published: 2012

Journal Articles

Randomized Trial On GvHD Prophylaxis with or without Anti T Cell Globulin ATG Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Updated Results and Evaluation of the European Group for Blood and Marrow Transplantation (EBMT) Risk Score.

Juergen Finke, Claudia Schmoor, PhD, Wolfgang A. Bethge, MD, Hellmut Ottinger, MD, Matthias Stelljes, MD, Axel R. Zander, MD, Liisa Volin, Dominik Heim, MD, Rainer Schwerdtfeger, Hartmut Bertz, Olga Grishina, MD, Gerard Socie

Blood (2012) 120 (21): 3090.

https://doi.org/10.1182/blood.V120.21.3090.3090

Published: 2012

Journal Articles

Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated Donors

Ahmet H Elmaagacli, MD, PhD, Michael Koldehoff, MD, Nina Kristin Steckel, Markus Ditschkowski, Rudolf Trenschel, MD, Hellmut Ottinger, Dietrich W. Beelen, MD

Blood (2012) 120 (21): 4182.

https://doi.org/10.1182/blood.V120.21.4182.4182

Published: 2012

Journal Articles

Results of Simultaneously Performed Analysis of 48 Gene Variants Reported to Have Influence on Transplant outcome

Ahmet Elmaagacli, MD, Michael Koldehoff, MD, Nina Steckel, Hellmut Ottinger, Dietrich Beelen

Blood (2011) 118 (21): 3047.

https://doi.org/10.1182/blood.V118.21.3047.3047

Published: 2011

Journal Articles

Chronic Graft-Versus-Host Disease: Lessons From a Randomized Trial on GvHD Prophylaxis with or without Anti-T-Cell Globulin ATG-Fresenius (ATG-F) In Allogeneic Hematopoietic Cell Transplantation (HSCT) From Matched Unrelated Donors

Gérard Socié, Claudia Schmoor, Wolfgang Andreas Bethge, Hellmut Ottinger, Matthias Stelljes, Axel R. Zander, MD, Liisa Volin, Dominik Heim, MD, Rainer Schwerdtfeger, MD, Hartmut Bertz, Olga Grishina, Jurgen Finke, MD

Blood (2010) 116 (21): 212.

https://doi.org/10.1182/blood.V116.21.212.212

Published: 2010

Journal Articles

A Cytomegalovirus Reactivation Is Associated with An Improved Progression-Free Survival Rate In Patients with Lymphoma After Allogeneic Transplant

Ahmet H Elmaagacli, Sandra Christoph, Michael Koldehoff, MD, Nina Steckel, Rudolf Trenschel, Hellmut Ottinger, Dietrich Beelen

Blood (2010) 116 (21): 4912.

https://doi.org/10.1182/blood.V116.21.4912.4912

Published: 2010

Journal Articles

Toll-Like-Receptor Expression and Cellular Immune Reconstitution In AML-Patients with Elevated Serum Ferritin Levels After Allogeneic transplant.

Ahmet Elmaagacli, Nina Steckel, Michael Koldehoff, MD, Sandra Christoph, Hellmut Ottinger, Rudolf Trenschel, Dietrich Beelen

Blood (2010) 116 (21): 1049.

https://doi.org/10.1182/blood.V116.21.1049.1049

Published: 2010

Journal Articles

Randomized Trial on GvHD Prophylaxis with or without Anti-T-Cell Globulin ATG-Fresenius (ATG-F) In Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Final Results and Analysis of Prognostic Factors

Jurgen Finke, MD, Claudia Schmoor, Wolfgang Andreas Bethge, Hellmut Ottinger, Matthias Stelljes, Axel R. Zander, MD, Liisa Volin, Dominik Heim, MD, Rainer Schwerdtfeger, MD, Hartmut Bertz, Olga Grishina, Gérard Socié

Blood (2010) 116 (21): 1249.

https://doi.org/10.1182/blood.V116.21.1249.1249

Published: 2010

Journal Articles

No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donors

Ahmet H. Elmaagacli, Nina Steckel, Markus Ditschkowski, Yael Hegerfeldt, Hellmut Ottinger, Rudolf Trenschel, Dietrich W. Beelen

Blood (2010) 115 (17): 3644–3645.

https://doi.org/10.1182/blood-2010-02-267443

Published: 2010

Journal Articles

Cytomegalovirus Reduces the Relapse Risk for Acute Leukemia After Transplant: There Is a Virus-Versus-Leukemia Effect.

Ahmet H Elmaagacli, Monika Lindemann, Bertram Opalka, Michael Koldehoff, Tania Gromke, Hellmut Ottinger, Rudolf S. Ross, Sebastian Bauer, Inken Hilgendorf, MD, Dietrich W. Beelen, MD

Blood (2009) 114 (22): 2261.

https://doi.org/10.1182/blood.V114.22.2261.2261

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation for Acquired Aplastic Anemia: Better Outcome with Bone Marrow as Compared to Peripheral Blood in HLA-Matched Sibling Donor Transplantation and Improved Outcome Over Time After Matched Unrelated Donor Transplantation. A Retrospective Analysis of Transplants Reported to the German Registry for Stem Cell Transplantation (DRST).

Hubert Schrezenmeier, Ulrike Feldmann, Hellmut Ottinger, Matthias Eder, Monika Führer, Hans-Jochem Kolb, Axel Zander, Karin Kolbe, Dietger Niederwieser, Donald W. Bunjes, MD, PhD, Rainer Schwerdtfeger, MD, Rupert Handgretinger, Karl Welte, Carlheinz Müller, Gerhard Ehninger, Jürgen Finke, Dietrich Beelen

Blood (2009) 114 (22): 876.

https://doi.org/10.1182/blood.V114.22.876.876

Published: 2009

Journal Articles

Shift to a New Donor Does Not Improve the Outcome After Second Allogeneic Stem Cell Transplantation (alloSCT) in Acute Leukemia Relapse After a First Allosct – a Risk Factor Analysis by the German Stem Cell Registry (DRST).

Blood (2009) 114 (22): 3328.

https://doi.org/10.1182/blood.V114.22.3328.3328

Published: 2009

Journal Articles

A Randomized Prospective Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors

Blood (2008) 112 (11): 57.

https://doi.org/10.1182/blood.V112.11.57.57

Published: 2008

Journal Articles

Adoptive Donor T-Cell Infusions Are Necessary and Efficient To Induce Lasting Molecular Remissions after Highly Purified CD34+ Sibling Donor Transplants for First Chronic Phase Chronic Myeloid Leukemia - Final Report and Long-Term Follow-Up of a Phase II Study.

Ahmet Elmaagacli, MD, Rudolf Peceny, M.D., Michael Koldehoff, M.D., Hellmut Ottinger, M.D., Rudolf Trenschel, M.D., Nina K. Steckel, M.D., Dietrich W. Beelen, M.D.

Blood (2006) 108 (11): 3017.

https://doi.org/10.1182/blood.V108.11.3017.3017

Published: 2006

NARROW

Impact of Donor-Recipient Histocompatibility and CMV-Mismatch on Outcome of Allogeneic Stem Cell Transplantation for AML and MDS: A Retrospective Registry Study of the German Stem Cell Transplant Registry (DRST) of the German Working Group for Blood and Marrow Transplantation (DAG-KBT)

Randomized Trial on GvHD Prophylaxis with or without Anti-Human T-Lymphocyte Immunoglobulin ATG-Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation from Matched Unrelated Donors: Final Long-Term Results after 8.6 Years Median Follow-up

The Functional Distance Between Mismatched HLA-DPB1 Increases Risks of Relapse and Mortality after Unrelated Donor Hematopoietic Cell Transplantation for AML, ALL and MDS: A Refinement of the T Cell Epitope Group Algorithm for Permissive Mismatches

Reduced Relapse Risk In Patients With AML After Hhcmv-Replication Post Transplantation-First Results Of a Prospective Registration Trial

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Human Chorionic Gonadotropin Hormone Induces Indoleamine 2,3-Dioxygenase and Interleukin-10 Expression In Patients With Graft-Versus-Host-Disease

CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in Lymphoma

Randomized Trial On GvHD Prophylaxis with or without Anti T Cell Globulin ATG Fresenius (ATG-F) in Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Updated Results and Evaluation of the European Group for Blood and Marrow Transplantation (EBMT) Risk Score.

Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated Donors

Results of Simultaneously Performed Analysis of 48 Gene Variants Reported to Have Influence on Transplant outcome

Chronic Graft-Versus-Host Disease: Lessons From a Randomized Trial on GvHD Prophylaxis with or without Anti-T-Cell Globulin ATG-Fresenius (ATG-F) In Allogeneic Hematopoietic Cell Transplantation (HSCT) From Matched Unrelated Donors

A Cytomegalovirus Reactivation Is Associated with An Improved Progression-Free Survival Rate In Patients with Lymphoma After Allogeneic Transplant

Toll-Like-Receptor Expression and Cellular Immune Reconstitution In AML-Patients with Elevated Serum Ferritin Levels After Allogeneic transplant.

Randomized Trial on GvHD Prophylaxis with or without Anti-T-Cell Globulin ATG-Fresenius (ATG-F) In Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Final Results and Analysis of Prognostic Factors

No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donors

Cytomegalovirus Reduces the Relapse Risk for Acute Leukemia After Transplant: There Is a Virus-Versus-Leukemia Effect.

Shift to a New Donor Does Not Improve the Outcome After Second Allogeneic Stem Cell Transplantation (alloSCT) in Acute Leukemia Relapse After a First Allosct – a Risk Factor Analysis by the German Stem Cell Registry (DRST).

A Randomized Prospective Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors

Adoptive Donor T-Cell Infusions Are Necessary and Efficient To Induce Lasting Molecular Remissions after Highly Purified CD34+ Sibling Donor Transplants for First Chronic Phase Chronic Myeloid Leukemia - Final Report and Long-Term Follow-Up of a Phase II Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only